Literature DB >> 11742142

Motor deficits in fibroblast growth factor receptor-3 null mutant mice.

M P McDonald1, K M Miller, C Li, C Deng, J N Crawley.   

Abstract

Fibroblast growth factor receptor-3 (FGFR-3) regulates aspects of bone development. Mutations in the FGFR-3 gene (Fgfr3) in humans and mice produce vertebral abnormalities and bone deformities. The present study evaluated the behavioural concomitants of the Fgfr3-/- mutation. Fgfr3-/- null mutant mice displayed severe impairments of motor abilities as detected on the rotarod, wire hang and open field tests. Absence of prepulse inhibition of acoustic startle was seen at prepulse levels from 74 to 86 dB. The motor deficits appear to be a direct and predicted consequence of the skeletal kyphosis, scoliosis and long bone overgrowth previously reported in Fgfr3 null mutant mice. The behavioural phenotype displayed by these mutant mice complements their anatomical, physiological and biochemical phenotypes, to complete the characterization of the functional outcome of a single gene mutation. Simple, robust behavioural symptoms, such as poor rotorod performance in Fgfr3 knockout mice, can provide useful surrogate markers to evaluate pharmacological treatments and gene therapies for human genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742142     DOI: 10.1097/00008877-200111000-00009

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

Review 1.  Neurodevelopmental implications of "deformational" plagiocephaly.

Authors:  Brent Collett; David Breiger; Darcy King; Michael Cunningham; Matthew Speltz
Journal:  J Dev Behav Pediatr       Date:  2005-10       Impact factor: 2.225

2.  Sociability and motor functions in Shank1 mutant mice.

Authors:  Jill L Silverman; Sarah M Turner; Charlotte L Barkan; Seda S Tolu; Roheeni Saxena; Albert Y Hung; Morgan Sheng; Jacqueline N Crawley
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

3.  Rare variant based evidence for oligogenic contribution of neurodevelopmental pathway genes to schizophrenia.

Authors:  Jibin John; Prachi Kukshal; Triptish Bhatia; V L Nimgaonkar; S N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2019-01-04       Impact factor: 4.939

4.  Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index.

Authors:  Alice E Kane; Sarah N Hilmer; Dawn Boyer; Kristan Gavin; Dawn Nines; Susan E Howlett; Rafael de Cabo; Sarah J Mitchell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-02-22       Impact factor: 6.053

5.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid.

Authors:  Fiona E Harrison; Sarah S Yu; Kristen L Van Den Bossche; Liying Li; James M May; Michael P McDonald
Journal:  J Neurochem       Date:  2008-05-07       Impact factor: 5.372

8.  A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism.

Authors:  A Dhanushkodi; E O Akano; E E Roguski; Y Xue; S K Rao; S G Matta; T S Rex; M P McDonald
Journal:  Genes Brain Behav       Date:  2012-11-28       Impact factor: 3.449

9.  Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.

Authors:  Anandh Dhanushkodi; Michael P McDonald
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.